Literature DB >> 20926632

Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling.

Masanori Kugita1, Kazuhiro Nishii, Miwa Morita, Daisuke Yoshihara, Hiroe Kowa-Sugiyama, Kouji Yamada, Tamio Yamaguchi, Darren P Wallace, James P Calvet, Hiroki Kurahashi, Shizuko Nagao.   

Abstract

Han:SPRD Cy is a spontaneous rat model of polycystic kidney disease (PKD) caused by a missense mutation in Pkdr1. Cystogenesis in this model is not clearly understood. In the current study, we performed global gene expression profiling in early-stage PKD cyst development in Cy/Cy kidneys and normal (+/+) kidneys at 3 and 7 days of postnatal age. Expression profiles were determined by microarray analysis, followed by validation with real-time RT-PCR. Genes were selected with over 1.5-fold expression changes compared with age-matched +/+ kidneys for canonical pathway analysis. We found nine pathways in common between 3- and 7-day Cy/Cy kidneys. Three significantly changed pathways were designated "Vitamin D Receptor (VDR)/Retinoid X Receptor (RXR) Activation," "LPS/IL-1-Mediated Inhibition of RXR Function," and "Liver X Receptor (LXR)/RXR Activation." These results suggest that RXR-mediated signaling is significantly altered in developing kidneys with mutated Pkdr1. In gene ontology analysis, the functions of these RXR-related genes were found to be involved in regulating cell proliferation and organ morphogenesis. With real-time RT-PCR analysis, the upregulation of Ptx2, Alox15b, OSP, and PCNA, major markers of cell proliferation associated with the RXR pathway, were confirmed in 3- and 7-day Cy/Cy kidneys compared with 3-day +/+ kidneys. The increased RXR protein was observed in both the nucleus and cytoplasm of cystic epithelial cells in early-stage Cy/Cy kidneys, and the RXR-positive cells were strongly positive for PCNA staining. Taken together, cell proliferation and organ morphogenesis signals transduced by RXR-mediated pathways may have important roles for cystogenesis in early-stage PKD in this Pkdr1-mutated Cy rat.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926632     DOI: 10.1152/ajprenal.00470.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  9 in total

1.  Role of genetic modifiers in an orthologous rat model of ARPKD.

Authors:  Caitlin C O'Meara; Matthew Hoffman; William E Sweeney; Shirng-Wern Tsaih; Bing Xiao; Howard J Jacob; Ellis D Avner; Carol Moreno
Journal:  Physiol Genomics       Date:  2012-06-05       Impact factor: 3.107

Review 2.  Systems biology of polycystic kidney disease: a critical review.

Authors:  Luis Fernando Menezes; Gregory G Germino
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2015-02-02

3.  Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.

Authors:  Susanne N E Boehn; Sonja Spahn; Sabine Neudecker; Andrea Keppler; Marie-Thérèse Bihoreau; Bettina Kränzlin; Priyanka Pandey; Sigrid C Hoffmann; Li Li; Vicente E Torres; Hermann-Josef Gröne; Norbert Gretz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

Review 4.  New treatments for autosomal dominant polycystic kidney disease.

Authors:  Ming-Yang Chang; Albert C M Ong
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

5.  Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease.

Authors:  Daisuke Yoshihara; Masanori Kugita; Tamio Yamaguchi; Harold M Aukema; Hiroki Kurahashi; Miwa Morita; Yoshiyuki Hiki; James P Calvet; Darren P Wallace; Takafumi Toyohara; Takaaki Abe; Shizuko Nagao
Journal:  PPAR Res       Date:  2012-05-13       Impact factor: 4.964

Review 6.  Pathway identification through transcriptome analysis.

Authors:  Takeshi Terabayashi; Gregory G Germino; Luis F Menezes
Journal:  Cell Signal       Date:  2020-07-07       Impact factor: 4.850

Review 7.  Vitamin D Receptor: A Novel Therapeutic Target for Kidney Diseases.

Authors:  Shikun Yang; Aimei Li; JianWen Wang; Jun Liu; Yachun Han; Wei Zhang; Yan Chun Li; Hao Zhang
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 8.  Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD.

Authors:  Roberto Pagliarini; Christine Podrini
Journal:  Front Med (Lausanne)       Date:  2021-11-24

9.  Characterization of the SAM domain of the PKD-related protein ANKS6 and its interaction with ANKS3.

Authors:  Catherine N Leettola; Mary Jane Knight; Duilio Cascio; Sigrid Hoffman; James U Bowie
Journal:  BMC Struct Biol       Date:  2014-07-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.